|Bid||84.77 x 900|
|Ask||84.78 x 1000|
|Day's Range||84.44 - 85.47|
|52 Week Range||58.49 - 86.41|
|Beta (5Y Monthly)||0.56|
|PE Ratio (TTM)||27.08|
|Earnings Date||Jan 29, 2021|
|Forward Dividend & Yield||1.76 (2.08%)|
|Ex-Dividend Date||Oct 22, 2020|
|1y Target Est||83.58|
Colgate-Palmolive (NYSE: CL) is a familiar name to many investors. Investing in companies that you understand is always good, and it is one of the key tenets of famed investor Peter Lynch's investing guidelines. Under its leading Colgate brand, the company sells toothpastes and toothbrushes.
Laboratory studies show that toothpastes containing zinc or stannous and mouthwash formulas with cetylpyridinium chloride (CPC) neutralize the virus that causes COVID-19 by 99.9 percent. The studies are part of a Colgate research program that includes clinical studies among infected people to assess the efficacy of oral care products in reducing the amount of the virus in the mouth, potentially slowing the transmission of the COVID-19 virus.
Colgate-Palmolive (NYSE:CL) Group President, Colgate-Latin America, Asia Pacific & Africa-Eurasia, Panagiotis Tsourapas, will participate in a virtual fireside chat at the Morgan Stanley Global Consumer & Retail Conference on Wednesday, December 2, 2020 at 11:00 a.m. ET.